MicroRNAs and drug modulation in cancer: an intertwined new story
- 1 October 2011
- journal article
- Published by Springer Nature in Frontiers in Biology
- Vol. 6 (5) , 351-356
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDFCancer Research, 2010
- The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional responseProceedings of the National Academy of Sciences, 2009
- MicroRNA-34b and MicroRNA-34c Are Targets of p53 and Cooperate in Control of Cell Proliferation and Adhesion-Independent GrowthCancer Research, 2007
- MicroRNAs and Cell Cycle RegulationCell Cycle, 2007
- p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor GenesCurrent Biology, 2007
- Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes ApoptosisMolecular Cell, 2007
- Deletion of Chromosome 11q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast CancerCancer Research, 2007
- RNA polymerase III transcribes human microRNAsNature Structural & Molecular Biology, 2006
- Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAsRNA, 2004
- MicroRNAsCell, 2004